SALIM VIRANI to Drug-Eluting Stents
This is a "connection" page, showing publications SALIM VIRANI has written about Drug-Eluting Stents.
Connection Strength
0.345
-
Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. Am J Cardiol. 2017 Nov 01; 120(9):1514-1520.
Score: 0.138
-
Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clin Cardiol. 2012 May; 35(5):291-6.
Score: 0.096
-
Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project. JAMA Cardiol. 2021 05 01; 6(5):574-580.
Score: 0.045
-
Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry). Am J Cardiol. 2019 12 15; 124(12):1807-1812.
Score: 0.040
-
Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of =70 years. Am J Cardiol. 2013 Sep 01; 112(5):615-22.
Score: 0.026